BCM
IBIO icon

Bridgeway Capital Management’s iBio IBIO Stock Holding History

Bridgeway Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,250
Closed -$52K – 1419
2023
Q1 		$52K Hold
1,250
– – ﹤0.01% 1309
2022
Q4 		$11.1K Buy
+1,250
New +$42.3K ﹤0.01% 1358
2022
Q1 		– Sell
-200
Closed -$55K – 1333
2021
Q4 		$55K Hold
200
– – ﹤0.01% 1241
2021
Q3 		$106K Hold
200
– – ﹤0.01% 1248
2021
Q2 		$151K Hold
200
– – ﹤0.01% 1284
2021
Q1 		$154K Buy
+200
New +$174K ﹤0.01% 1301

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return